Personas / Equipo Humano

José Ángel Alda Díez

Buscador de publicaciones

Publicaciones

  • Alda JA and Serrano E.

    Attention-Deficit Hyperactivity Disorder: Agreement between Clinical Impression and the SNAP-IV Screening Tool

    ACTAS ESPANOLAS DE PSIQUIATRIA . 41(2): 76-83. Nº de citas: 19

  • Montoya A, Hernández S, Massana MP, Herreros O, Garcia-Giral M, Cardo E, Alda JA, Soutullo C, Fernández-Jaén A and Fuentes J.

    Evaluating Internet information on attention-deficit/hyperactivity disorder (ADHD) treatment: parent and expert perspectives.

    Education for health (Abingdon, England) . 26(1): 48-53.

    [doi:10.4103/1357-6283.112801]

  • Serrano E, Guidi M and Alda JA.

    Is psychological treatment efficacious for attention deficit hyperactivity disorder (ADHD)? Review of non-pharmacological treatments in children and adolescents with ADHD

    ACTAS ESPANOLAS DE PSIQUIATRIA . 41(1): 44-51. Nº de citas: 26

  • Merchán-Naranjo J, Tapia C, Bailón C, Moreno C, Baeza I, Calvo-Escalona R, Morer A, Martínez-Cantarero C, Nestares PA, Alda JA, Muñoz D and Arango C.

    Secondary effects of antipsychotic treatment in naive or quasi-naive children and adolescents: Design of a follow-up protocol and baseline results

    Spanish journal of psychiatry and mental health . 5(4): 217-228. Nº de citas: 15

    [doi:10.1016/j.rpsm.2012.03.006]

  • Montoya A, Escobar R, García-Polavieja MJ, Lachno DR, Alda JA, Artigas J, Cardo E, García M, Gastaminza X and Gilaberte I.

    Changes of Urine Dihydroxyphenylglycol to Norepinephrine Ratio in Children With Attention-Deficit Hyperactivity Disorder (ADHD) Treated With Atomoxetine

    JOURNAL OF CHILD NEUROLOGY . 26(1): 31-36. Nº de citas: 10

    [doi:10.1177/0883073810371981]

  • Serrano E, Ezpeleta L, Alda JA, Matalí JL and San L.

    Psychometric Properties of the Young Mania Rating Scale for the Identification of Mania Symptoms in Spanish Children and Adolescents with Attention Deficit/Hyperactivity Disorder

    Psychopathology . 44(2): 125-132. Nº de citas: 7

    [doi:10.1159/000320893]

  • Montañés-Rada F, Gastaminza-Pérez X, Catalá MA, Ruiz-Sanz F, Ruiz-Lázaro PM, Herreros-Rodríguez O, García-Giral M, Ortiz-Guerra J, Alda JA, Mojarro-Práxedes D, Cantó-Díez T, Mardomingo-Sanz MJ, Sasot-Llevadot J, Pàmias M and Rey-Sánchez F.

    Consenso del GEITDAH sobre el trastorno por deficit de atencion/hiperactividad.

    REVISTA DE NEUROLOGIA . 51(10): 633-637. Nº de citas: 9

    [doi:10.33588/rn.5110.2010383]

  • Moreno C, Merchán-Naranjo J, Alvarez M, Baeza I, Alda JA, Martínez-Cantarero C, Parellada M, Sánchez B, de la Serna E, Giráldez M and Arango C.

    Metabolic effects of second-generation antipsychotics in bipolar youth: comparison with other psychotic and nonpsychotic diagnoses

    BIPOLAR DISORDERS . 12(2): 172-184. Nº de citas: 42

    [doi:10.1111/j.1399-5618.2010.00797.x]

  • Montoya A, Hervás A, Cardo E, Artigas J, Mardomingo MJ, Alda JA, Gastaminza X, García-Polavieja MJ, Gilaberte I and Escobar R.

    Evaluation of atomoxetine for first-line treatment of newly diagnosed, treatment-naive children and adolescents with attention deficit/hyperactivity disorder

    CURRENT MEDICAL RESEARCH AND OPINION . 25(11): 2745-2754. Nº de citas: 54

    [doi:10.1185/03007990903316152]

  • Rajmil L, Estrada MD, Herdman M, Serra-Sutton V, Tebé C, JON IZAGUIRRE EGUREN, Alda JA, Alonso J, Riley AW, Forrest CB and Starfield B.

    Concordancia entre padres e hijos en la calidad de vida relacionada con la salud en niños con trastorno por déficit de atención con hiperactividad: estudio longitudinal.

    ANALES DE PEDIATRIA . 70(6): 553-561. Nº de citas: 10

    [doi:10.1016/j.anpedi.2008.12.007]